OnabotulinumtoxinA as a promising treatment for primary trochlear headache: A retrospective case series

CONCLUSIONS: Our case series presents the first evidence of the potential of BoNTA as a safe and effective treatment option for PRTH. From a clinical standpoint, having a safer alternative is of paramount significance for patients with limited treatment options, such as those with PRTH. Further research is warranted to validate these findings and explore the long-term efficacy of BoNTA in PRTH management.PMID:38533675 | DOI:10.1111/head.14699
Source: Headache - Category: Neurology Authors: Source Type: research